# India publishes revised maximum prices for 543 cancer medicine brands

> India’s National Pharmaceutical Pricing Authority released revised maximum retail prices for 543 anti-cancer medicine brands on 28 October.

- Canonical URL: https://newsverum.com/en/news/india-nppa-543-cancer-medicine-brands-revised-prices-2026
- Publisher: Newsverum
- Section: Health
- Country: India
- Published: 2026-10-28T15:57:55+00:00
- Updated: 2026-10-28T15:57:55+00:00
- Event / data period: 2026-10-28
- Other editions: [Türkçe](https://newsverum.com/tr/news/india-nppa-543-cancer-medicine-brands-revised-prices-2026.md), [العربية](https://newsverum.com/ar/news/india-nppa-543-cancer-medicine-brands-revised-prices-2026.md), [Français](https://newsverum.com/fr/news/india-nppa-543-cancer-medicine-brands-revised-prices-2026.md), [Español](https://newsverum.com/es/news/india-nppa-543-cancer-medicine-brands-revised-prices-2026.md), [Deutsch](https://newsverum.com/de/news/india-nppa-543-cancer-medicine-brands-revised-prices-2026.md), [Português](https://newsverum.com/pt/news/india-nppa-543-cancer-medicine-brands-revised-prices-2026.md)

India’s National Pharmaceutical Pricing Authority released revised maximum retail prices for 543 anti-cancer medicine brands on 28 October. The new prices take effect on 9 November 2026, according to the Department of Pharmaceuticals announcement.

The list reflects manufacturers’ submissions received through 27 October and will be updated as further revised prices arrive. It follows the authority’s 17 October decision to rationalise trade margins on 137 non-scheduled anti-cancer drugs. Brand counts and drug counts measure different things and should not be added together.

For example, the published table lists Anarzole 1 mg tablets in a ten-tablet pack at a revised maximum price of 73 rupees, compared with 695.76 rupees previously. The figures concern that stated brand, strength and pack. They do not establish the price of every anastrozole product or whether new prices are already being charged before the effective date.

## Data

### Source publication

Publication of the official announcement on 28 October 2026.

Methodology: The date records publication of the cited official source. It does not establish completion of announced future actions.

| date | label | description | status |
|---|---|---|---|
| 2026-10-28 | India publishes revised maximum prices for 543 cancer medicine brands | India’s National Pharmaceutical Pricing Authority released revised maximum retail prices for 543 anti-cancer medicine brands on 28 October. The new prices take effect on 9 November 2026, according to the Department of Pharmaceuticals announcement. | occurred |

Sources: <https://www.pib.gov.in/PressReleseDetailm.aspx?PRID=2329698> · Download data: [JSON](https://newsverum.com/api/v1/articles/india-nppa-543-cancer-medicine-brands-revised-prices-2026/data/source-announcement?lang=en&format=json) · [CSV](https://newsverum.com/api/v1/articles/india-nppa-543-cancer-medicine-brands-revised-prices-2026/data/source-announcement?lang=en&format=csv)

## Sources

- [Press Information Bureau, Government of India](<https://www.pib.gov.in/PressReleseDetailm.aspx?PRID=2329698>) (Source checked: 2026-10-28; Published: 2026-10-28)

---

Cite the canonical URL above. [Editorial standards and corrections](https://newsverum.com/en/editorial)
